LifeScience Biologics

Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology

This marks Cresilon's first FDA clearance for human use, validating its revolutionary hemostatic gel technology and the company's global mission to transfo...

 June 30, 2023 | News

BGI Genomics obtains BSI ISO 37301 Compliance Management System Certification

BGI Genomics prioritizes compliance management and strictly follows laws, regulations, and international practices while conducting business globally. BGI ...

 June 30, 2023 | News

Thermo Fisher Scientific Introduces Tumor Culture Medium for Faster Cancer Treatment Development

Thermo Fisher Scientific, a global leading company in science services, today announced the launch of the Gibco™ OncoPro™ tumor media kit. *, t...

 June 29, 2023 | News

Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET™ technology

By using this cutting-edge imaging technology in preclinical studies, Oncodesign Services’ team hopes to gain insights of the predictive effectivenes...

 June 29, 2023 | News

OBiO Technology adds scale-X™ and NevoLine™ Upstream Platform to Accelerate Gene Therapy Manufacturing in Shanghai

  The strategic agreement combines the capacity and capabilities of OBiO process development (PD) scientists with enabling platforms and support from...

 June 28, 2023 | News

Lymphoma Therapy Approved for Australian Patients with Diffuse Large B-cell Lymphoma

MINJUVI® (tafasitamab) provisionally approved by Therapeutic Goods Administration[1] Recent five-year follow-up data from Phase 2 L-MIND investig...

 June 28, 2023 | News

INOVIQ's SubB2M/CA15-3 Breast Cancer Test Shows Excellent Clinical Data

INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) The...

 June 28, 2023 | News

Innovent and RemeGen Collaborate on Clinical Trial for Combined Therapy of TYVYT® and Novel ADCs in China

Under the agreement, Innovent will provide clinical drug supplies of TYVYT® (sintilimab injection) during the clinical trial collaboration. RemeGen wil...

 June 26, 2023 | News

Brii Biosciences to Sell Equity Interest in Qpex Biopharma and Acquire Global Rights for BRII-693

Company acquires exclusive global rights of the novel lipopeptide BRII-693 for the difficult to treat MDR/XDR gram-negative bacterial infections &nbs...

 June 26, 2023 | News

Cognigenics' Intranasal CRISPR Delivery Overcomes Blood-Brain Barrier; Promising Therapeutic Breakthrough

Cognigenics CEO John L. Mee announces breakthrough results from an animal study published today in PNAS Nexus. The findings point to the pot...

 June 23, 2023 | Analysis

Anthem Biosciences Partners with Veeva to Drive Quality Excellence

 Veeva Systems (NYSE: VEEV)  announced that fast-growing contract development and manufacturing organization (CDMO) Anthem Biosciences&...

 June 22, 2023 | News

Everest Medicines' Partner Calliditas Presents Nefecon Data at ERA-EDTA Congress

The presentations showed data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon in patients with IgA nephropathy (IgAN). The study m...

 June 21, 2023 | News

GenScript Debuts AmMag™ Quatro to Revolutionize Automated Plasmid Maxi-Prep Purification

 GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has added the AmMag™ Quatro a...

 June 21, 2023 | News

Curocell Announces Positive Updates on Next-Gen Anti-CD19 CAR-T at ICML 2023

  84% ORR (32 of 38 patients) and 71% CR (27 of 38 patients) documented after 2 million cells/kg dose anbal-cel treatment to patients in relap...

 June 20, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close